Rein Therapeutics Inc. (RNTX)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | 8-K (2025-05-15) · 99.1 | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | 8-K (2024-11-14) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-15) · 99.1 | 8-K (2024-05-01) | ||
| 10-K/A | FY-2023 | |||
| 10-K | FY-2023 | 8-K (2024-04-15) · 99.1 | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — | ||
| 10-K/A | FY-2022 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Condensed Balance Sheets | — |
|
| Consolidated Balance Sheets | ||
| Condensed Balance Sheets (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Condensed Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Statements of Operations and Comprehensive Loss (P) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss (P) | ||
| Condensed Statement of Stockholders' Equity (unaudited) | — |
|
| Consolidated Statement of Changes In Convertible Preferred Stock and Stockholders' Equity | ||
| Consolidated Statement of Changes In Convertible Preferred Stock and Stockholders' Equity (P) | — |
|
| Consolidated Statements of Cash Flows | ||
| Statements of Cash Flows | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Business Acquisition | ||
| Commitments and Contingencies | ||
| Common Stock | ||
| Compensation | — |
|
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Fair Value of Financial Assets | ||
| Goodwill and Indefinite-lived Intangible Assets | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Investments | — |
|
| Lease | — |
|
| Nature of The Business | ||
| Nature of The Business and Basis of Presentation | — |
|
| Net Loss Per Share | ||
| Notes Payable | — |
|
| Other Asset | ||
| Pay Vs Performance Disclosure | ||
| Preferred Stock | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment, Net | ||
| Related Party Transactions | ||
| Restructuring and Other Costs | ||
| Segment Reporting | ||
| Stock-based Awards | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||